Peter Greenleaf
Director at Pelthos Therapeutics Inc. (PTHS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $54K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 6SEC | PTHSPelthos Therapeutics Inc. | Sell Plan | 79723,087 held (−3%) | $21.17 | $17K | -3.2% |
| Jul 7SEC | PTHSPelthos Therapeutics Inc. | Sell Plan | 71223,969 held (−3%) | $26.00 | $19K | -21.2% |
| Jul 7SEC | PTHSPelthos Therapeutics Inc. | Sell Plan | 8523,884 held (−0%) | $27.27 | $2K | -24.8% |
| Apr 6SEC | PTHSPelthos Therapeutics Inc. | Sell Plan | 42025,058 held (−2%) | $20.52 | $9K | -0.1% |
| Apr 6SEC | PTHSPelthos Therapeutics Inc. | Sell Plan | 37724,681 held (−2%) | $21.36 | $8K | -4.0% |
- Sell
Director Peter Greenleaf sold $17K of PTHS at $21.17 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Peter Greenleaf sold $19K of PTHS at $26.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Peter Greenleaf sold $2K of PTHS at $27.27 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Peter Greenleaf sold $9K of PTHS at $20.52 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Peter Greenleaf sold $8K of PTHS at $21.36 — pre-scheduled 10b5-1 plan sale.